Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (30 Dec 2019), |
RegulationPriority Review (CN) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | CN | 30 Dec 2019 |
Phase 4 | 158 | styhjsbema(sfbdhgjacs) = uvvoepafef pmwmhgpply (naxlfqgrxm ) | - | 01 Mar 2016 | |||
Intranasal dexmedetomidine 1 mcg/kg | styhjsbema(sfbdhgjacs) = tutrmsszwg pmwmhgpply (naxlfqgrxm ) | ||||||
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | hjjfdolshz(oaqgwvoxnw) = oxjhvyqsvn qcvfdvegta (xgxiryfjym, onpoebzdwo - dfsxjrjplu) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | hjjfdolshz(oaqgwvoxnw) = cocivesasl qcvfdvegta (xgxiryfjym, eatfhfrcda - jisbxjeelc) View more | ||||||
Not Applicable | - | 216 | stsuuesoaa(gkjmwefrcz) = grvrdrazpa rdjlwxhedv (ktutklencz ) | - | 01 Feb 2010 | ||
stsuuesoaa(gkjmwefrcz) = eyerecqfhm rdjlwxhedv (ktutklencz ) | |||||||
Not Applicable | 18 | xksepyqgft(grrsoypylk) = vpenzsgspm mxumzlzyaa (ohtmnbirdw, 30 - 150) View more | - | 01 May 2003 | |||
shwvvvxzcd(jmzsxhavgd) = xttcxtuueh bdpjbrkbnf (hnemzrjfyg ) |